Robert Ventures Secures SEC Qualification for Innovative Real Estate and Digital Asset Investment Vehicle
Wilmington, DE , Feb. 21, 2025 (GLOBE NEWSWIRE) -- Today, Robert Ventures…
MANTRA Chain Launches Real-World Asset Accelerator Supported by Google Cloud
HONG KONG, Feb. 20, 2025 /PRNewswire/ -- MANTRA, a layer 1 blockchain purpose-built…
Radix Adds World-Class Supply Chain Resilience to Best-In-Class Asset Performance Management
HOUSTON, Jan. 26, 2025 (GLOBE NEWSWIRE) -- Radix, a global technology solutions…
Blockchain Security Meets Bitcoin Layer 2: True I/O and OroBit Join Forces to Transform Real-World Asset Markets
Carlsbad, CA , Jan. 21, 2025 (GLOBE NEWSWIRE) -- True I/O, a…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
This is the second asset Menarini Group has inlicensed from Insilico Medicine…